CD38 and Miyoshi myopathy: In light of the scarce immunological protection by vaccine, in these MM patients on active treatment with anti-CD38 monoclonal antibodies, IgG titer monitoring should be implemented and social distancing and mask wearing maintained regardless of vaccination status.